Association of a alpha1 Acidic Glycoprotein and Squamous Cell Carcinoma of the Head and Neck

María Virginia CROCE1, Mike R PRICE2, Amada SEGAL-EIRAS1

1Centro de Investigaciones Inmunológicas Básicas y Aplicadas (CINIBA), Facultad de Ciencias Médicas, UNLP, La Plata, Argentina
2Cancer Research Laboratory, School of Pharmaceutical Sciences, University of Nottingham, Nottingham, UK


Serum from patients with different malignancies contain an abnormal concentration of a a1-acidic-glycoprotein (AAG) and also, increased levels of AAG are associated with the presence of tumor mass. In the present report, serum levels of AAG were measured by radial immunodiffusion in squamous cell carcinoma of the head and neck (SCCHN) patients taking into account disease status parameters such as tumor localization, stage and extension of disease. Immunohistochemical methods, SDS-PAGE and Western-blotting were employed to study the expression of AAG and a carbohydrate related antigen (sialyl Lewis x) in tumor tissues and derived fractions. AAG showed abnormal levels in 7/15 oral cavity tumor patients’ sera, 2/5 oropharynx and 5/10 larynx tumors; increased AAG serum levels belonged to patients with disseminated disease. On the other hand, the presence of AAG and sialyl Lewis x were demonstrated in carcinoma cells and in derived fractions from tumor tissues belonging to patients with elevated AAG serum levels. In the present study, we have found elevated levels of AAG in serum samples from SCCHN patients; these neoplastic cells are capable to express AAG. Pathology & Oncology Research, Vol 7, Nr 2, 111-117, 2001

Key words: Head and neck cancer; alpha1 acidic-glycoprotein; disease stage

Received: Jan 15, 2001; accepted: Apr 10, 2001
Correspondence: Amada SEGAL-EIRAS, , ,

Click here to get the full-text version in PDF!